Kanabo Group Plc (LSE:KNB), a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, announces Kanabo’s CBD products
Kanabo Group PLC (KNB.L) Update: New contract signed by Materia
The Board of Kanabo notes the recent announcement published by Materia and are delighted that Materia’s wholly-owned subsidiary Materia Deutschland GmbH (“Materia Deutschland”), has entered into an agreement with German
Kanabo Group PLC (KNB.L) Initial Commercial Scale Production
Kanabo Group Plc (LSE: KNB), a London-based medical cannabis R&D company, announces that the Company, in partnership with Pure Origin Group, has completed its first EU-GMP production line.